Overcast 50°
Tag:

Branchburg, NJ

News
Bright Green Fireball Spotted By NJ, PA Residents Bright Green Fireball Spotted By NJ, PA Residents
Bright Green Fireball Spotted By NJ, PA Residents A bright green fireball lit up the sky on Wednesday night -- just after SpaceX's Crew-3 liftoff, Space.com reports. Nearly 500 people including some from New Jersey and Pennsylvania reported the fireball to the American Meteor Society. The Taurid fireball was visible at 9:12 EST on Nov. 10, just nine minutes after the SpaceX liftoff, the AMS said. The fireball first became visible 48 miles over Greenville, NC and moved northwest at 33,000 miles per hour -- surviving only 3.5 seconds before disintegrating above Macclesfield, the AMS reports. Several New Jersey residents took to Twitter to…

SHARE

by Cecilia Levine
Police & Fire
Authorities: Car Burglar Admits Breaking Into 2,000 Vehicles In New Jersey, Pennsylvania Authorities: Car Burglar Admits Breaking Into 2,000 Vehicles In New Jersey, Pennsylvania
Authorities: Car Burglar Admits Breaking Into 2,000 Vehicles In New Jersey, Pennsylvania Authorities have arrested a suspect who admits breaking into about 2,000 vehicles in New Jersey and Pennsylvania. Keith A. Johnson, 33, of Yardley, in Bucks County, PA, is charged with numerous counts of theft and burglary, as well as 76 counts of loitering/prowling at night, according to the Bucks County District Attorney's office. Johnson also admitted to stealing $140,000 in cash during a burglary in Philadelphia, detectives said in court papers, according to NJ Advance Media. When police searched Johnson's home, they found $30,000 in cash, plus items stolen from cars, they said. Johns…

SHARE

by Jon Craig
News
PA Drug Manufacturer Says New Antiviral Drug Shows Quick Reduction In COVID PA Drug Manufacturer Says New Antiviral Drug Shows Quick Reduction In COVID
PA Drug Manufacturer Says New Antiviral Drug Shows Quick Reduction In COVID Experimental antiviral drug molnupiravir being developed by New Jersey drug manufacturer Merck with Ridgeback Bio shows a quick reduction of the infectious virus in a study among participants with early COVID-19. Molnupiravir is being tested in a Phase 2/3 trial set to be completed in May. Merck will be provided with up to  $268.8 million in funding from the Biomedical Advanced Research and Development Authority within the U.S. Department of Health and Human Services. Associate Professor of Medicine at the University of North Carolina School of Medicine William Fis…

SHARE

by Cecilia Levine